Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Pfizer-BioNTech COVID-19 booster after two-dose Verocell regimen
TCTR20211023002Phase 4Completed
- Sponsor
- Lampang Hospital
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tozinameran in coronavirus disease 2019 (COVID-19), sponsored by Lampang Hospital. Primary endpoints: Safety, Tolerability and 1 more. Started Aug 2021; status: completed.
02
Drugs
tozinameran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20211023002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211023002.